ICU Medical vs West Pharmaceutical Services
West Pharmaceutical Services is the larger business, with $3.07bn of revenue in fiscal 2025 against $2.23bn for ICU Medical (1.4 times as much). West Pharmaceutical Services grew faster (6.3% against -6.3%). West Pharmaceutical Services kept more of each dollar of sales as profit: a net margin of 16.1% against 0.0%.
| Latest fiscal year | ICU MedicalICUI, 2025 | West Pharmaceutical ServicesWST, 2025 |
|---|---|---|
| Revenue | $2.23bn | $3.07bn |
| Revenue growth | -6.3% | 6.3% |
| Net income | $732,000 | $494m |
| Operating margin | — | 19.0% |
| Net margin | 0.0% | 16.1% |
| Return on equity | 0.0% | 16.9% |
| Free cash flow | $91.8m | $469m |
| Cash | $308m | $791m |
| Total debt | $1.29bn | $203m |
| Debt to equity | — | 6.4% |
| Dividend per share | — | $0.86 |
| Dividend yield | — | 0.2% |
| Share buybacks | $8.8m | $134m |
| Employees | 13,000 | — |
| Market value | $4.03bn | $28.63bn |
| Price vs our value range | Above our value range | Above our value range |
| Moat score | 35 (Weak) | 77 (Strong) |
| Insider trades, 12 months | 0 buys, 19 sales | 0 buys, 8 sales |